Edition:
United States

Achaogen Inc (AKAO.OQ)

AKAO.OQ on NASDAQ Stock Exchange Global Market

12.20USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$12.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
224,332
52-wk High
$27.78
52-wk Low
$4.84

Select another date:

Wed, Nov 8 2017

BRIEF-Achaogen reports Q3 loss per share $0.85

* Achaogen reports third quarter 2017 financial results and provides corporate update

BRIEF-Achaogen submits Plazomicin new drug application to FDA

* Achaogen submits Plazomicin new drug application (NDA) to the U.S. FDA for treatment of complicated urinary tract infections and bloodstream infections

BRIEF-Achaogen awarded up to $18 million contract by BARDA

* Achaogen awarded up to $18 million contract by BARDA to support development of orally-administered antibacterial candidate C-Scape

BRIEF-Achaogen reports Q2 loss per share $0.78

* Achaogen reports second quarter 2017 financial results and provides corporate update

BRIEF-Point72 Asset Management reports 5.5 pct passive stake in Achaogen

* Point72 Asset Management Lp reports 5.5 percent passive stake in Achaogen Inc as of july 25 - sec filing Source text - http://bit.ly/2vK96pV Further company coverage:

BRIEF-Achaogen says board increased size from nine directors to ten directors

* Achaogen says on July 11, in connection with Karen Bernstein's appointment, board increased size from nine directors to ten directors - SEC filing Source: (http://bit.ly/2vifzY4) Further company coverage:

BRIEF-Achaogen starts C-Scape clinical development program with phase 1 study of orally-administered antibacterial candidate

* Initiates c-scape clinical development program with phase 1 study of orally-administered antibacterial candidate

BRIEF-Achaogen announces pricing of public offering of common stock

* Achaogen announces pricing of public offering of common stock

Select another date: